Evidence map›Paper›PMID 35493481›Full record

ArticleFrontiers in immunology2022

Elastase- and LPS-Exposed Cpa3

Eduardo I Cardenas, Perla A Alvarado-Vazquez, Erika Mendez-Enriquez, Erik A Danielsson, Jenny Hallgren

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eduardo I CardenasDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Perla A Alvarado-VazquezDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Erika Mendez-EnriquezDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Erik A DanielssonDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Jenny HallgrenDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Uppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IL-33 and its receptor ST2, as well as mast cells and their mediators, have been implicated in the development of chronic obstructive pulmonary disease (COPD). However, whether mast cells and the ST2 receptor play a critical role in COPD pathophysiology remains unclear. Here, we performed repeated intranasal administrations of porcine pancreatic elastase and LPS for four weeks to study COPD-like disease in wildtype, ST2-deficient, and Cpa3

Indexed as

Pancreatic ElastasePulmonary Disease, Chronic ObstructiveAnimalsIntegrasesInterleukin-1 Receptor-Like 1 ProteinLipopolysaccharidesMiceSwineCre recombinaseIntegrasesInterleukin-1 Receptor-Like 1 ProteinLipopolysaccharidesPancreatic Elastaseairway hyperresposivenessCOPD - chronic obstructive pulmonary diseaseIL-33mast cell (MC)pulmonary functionST2

Identifiers

PMID35493481
PMCPMC9043106
OpenAlexW4223982620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.